Alan B. Glassberg
Corporate Officer/Principal en The University of California, San Francisco .
Cargos activos de Alan B. Glassberg
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | 01/01/1970 | - |
Historial de carrera de Alan B. Glassberg
Antiguos cargos conocidos de Alan B. Glassberg.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BIOGEN INC. | Director/Miembro de la Junta | 01/01/1997 | 01/06/2009 |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | Director/Miembro de la Junta | 01/01/1997 | 31/12/2008 |
| PONIARD PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 24/08/2006 | 15/03/2007 |
Aravive Biologics, Inc.
 Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Director/Miembro de la Junta | - | - |
Bay City Capital LLC
 Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Corporate Officer/Principal | 16/12/2010 | - |
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Director/Miembro de la Junta | 01/01/1997 | - |
Formación de Alan B. Glassberg.
| College of Charleston | Undergraduate Degree |
| Medical University of South Carolina | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 10 |
Operativa
| Director/Board Member | 4 |
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 4 |
| Finance | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| PONIARD PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Biogen Idec New Ventures, Inc.
Biogen Idec New Ventures, Inc. Investment ManagersFinance Founded in 2004, Biogen Idec New Ventures is the corporate venture group of Biogen Idec, Inc. In 2003, Biogen and IDEC Pharmaceuticals merged to create Biogen Idec, Inc. (NASDAQ: BIIB) | Finance |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
Bay City Capital LLC
Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Finance |
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Health Technology |
- Bolsa de valores
- Insiders
- Alan B. Glassberg
- Experiencia
